---
title: "Repatha (evolocumab) in cardiovascular event risk reduction: medical information"
description: "Questions on Repatha (evolocumab) in cardiovascular event risk reduction, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Indication, Clinical trials, Safety, Dosing and administration, and Guidelines. 14 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction"
published: "2026-11-13T03:43:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Repatha (evolocumab) in cardiovascular event risk reduction: medical information

Manufacturer: Amgen Inc.  
Prescribing information: [Repatha](https://www.pi.amgen.com/united_states/repatha/repatha_pi_hcp_english_current.pdf)

Questions that apply to every indication of Repatha are on [Repatha (evolocumab), all indications](https://www.evicenter.com/medical-information/repatha).

## [Indication](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/indication)

- [What is Repatha approved for in cardiovascular risk reduction?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/indication#repatha-cv-indication)

## [Clinical trials](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials)

- [Does Repatha reduce heart attacks and strokes in established cardiovascular disease (FOURIER)?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-fourier-results)
- [Did Repatha lower the risk of death in FOURIER?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-fourier-death)
- [Does Repatha reduce cardiovascular events without a prior heart attack or stroke (VESALIUS-CV)?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-vesalius-results)
- [Did Repatha lower the risk of death in VESALIUS-CV?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-vesalius-death)
- [Does Repatha reduce heart attacks in patients without a prior heart attack (VESALIUS-CV)?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-vesalius-heart-attack)
- [How much does Repatha lower LDL cholesterol in the cardiovascular outcomes trials?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/clinical-trials#repatha-ldl-cv-trials)

## [Safety](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/safety)

- [Does Repatha affect memory or cognitive function (EBBINGHAUS)?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/safety#repatha-cognitive-function)
- [What are the most common side effects of Repatha in cardiovascular outcomes trials?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/safety#repatha-cv-trial-side-effects)
- [Does Repatha increase the risk of diabetes?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/safety#repatha-diabetes-risk)
- [What did VESALIUS-CV show about Repatha's long-term safety?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/safety#repatha-long-term-side-effects)

## [Dosing and administration](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/dosing-and-administration)

- [What is the Repatha dose for cardiovascular risk reduction?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/dosing-and-administration#repatha-dose)

## [Guidelines](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/guidelines)

- [Repatha and LDL-C goals: what does the 2026 ACC/AHA guideline say?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/guidelines#repatha-guideline-ldl-goals)
- [Repatha: when does the 2026 ACC/AHA guideline recommend adding a PCSK9 inhibitor?](https://www.evicenter.com/medical-information/repatha--cardiovascular-event-risk-reduction/guidelines#repatha-guideline-pcsk9i)
